Viatris and Idorsia Announce Significant Global Research and Development Collaboration
Viatris Reported Q4 & FY 2023 Results, a Strong Finish to an Outstanding Year
We believe in healthcare as it should be – empowering people worldwide to live healthier through every stage of life.
We produce high quality medicines across a range of therapeutic areas spanning both noncommunicable & infectious diseases.
We are excited about who we are and the work we do every day, ensuring access to health for patients everywhere.
#J-18808-Ljbffr
Más información
- Address Madrid
